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Introduction
Neglected tropical diseases (NTDs) are communicable diseases that occur under conditions of
poverty and are concentrated almost exclusively in impoverished populations in the develop-
ing world. NTDs affect more than 1000 million people in tropical and subtropical countries,
costing developing economies billions of dollars every year. Effective control of NTDs can be
achieved with the use of large-scale delivery of single-dose preventive chemotherapy (PC) or
intensified disease management (IDM) or both, as is the case for some diseases such as lym-
phatic filariasis, trachoma, and yaws.
Several NTDs exhibit significant cutaneous manifestations that are associated with long-
term disfigurement and disability, including Buruli ulcer (BU); cutaneous leishmaniasis (CL);
leprosy; mycetoma; yaws; hydrocele and lymphoedema (resulting from lymphatic filariasis);
and depigmentation, subcutaneous nodules, severe itching, and hanging groin (resulting from
onchocerciasis). Skin examination offers an opportunity to screen people in the communities
or children in schools to identify multiple conditions in a single visit. This common approach
to skin diseases justifies the integrated delivery of health care interventions to both increase
cost-effectiveness and expand coverage.
WHO’s Department of Control of NTDs (WHO/NTD) plans to promote an integrated
strategy for the skin NTDs requiring IDM. Targeting skin NTDs also provides a platform for
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treatment of common skin conditions and, therefore, has wider public health benefits. An
informal panel of experts (writing this manuscript) was established to help develop guidance
in support of the new WHO strategic direction and to develop a proposal for a change in pol-
icy for the integrated control and management of the skin NTDs.
A symposium at the 2015 ASTMH meeting[1] initiated a discussion of opportunities
around integration of surveillance and control of NTDs that affect the skin, but this paper
moves these ideas forward and includes some initial recommendations about how these
opportunities could be realised. We aim to provide specific pragmatic information and actual
recommendations about potential surveillance and management approaches.
Burden of Skin NTDs
Skin NTDs are frequently co-endemic in many countries, districts, and communities (Table 1).
[2–9] While none of the skin NTDs are significant causes of mortality, they are responsible for a
large number of disability-adjusted life years (DALYs) lost.[10] For example, contractures and
resulting disability in BU, advanced lymphoedema and hydrocele in LF, the consequences of
permanent nerve damage in leprosy, amputations in mycetoma, and bone involvement in yaws
can lead to debilitating deformities and difficulty in securing employment.[11]
In addition, skin NTDs result in stigmatization, discrimination, and psychological distress,
which contribute to suffering and may affect health-seeking behaviours and adherence to
treatment.[12] Finally, the economic impact of accessing care and rehabilitative measures can
be substantial.[13]
Policy Change
In May 2013, the World Health Assembly (WHA) adopted resolution WHA66.12, which calls
on Member States to intensify and integrate control measures to improve the health of NTD-
affected populations.[14] Individual NTDs have WHA mandates, including the control of
morbidity due to BU, CL, filarial lymphoedema, the elimination of onchocerciasis, the achieve-
ment of elimination of leprosy as a public health problem, and the eradication of yaws. In May
2016, the WHA adopted a resolution on mycetoma that called for the need to develop diagnos-
tic tests and simpler treatment as well as enhanced surveillance.[15]
For many years, vertical disease programmes were established to deal with priority diseases,
but, increasingly, there has been a move to integrate programmes into general health services.
WHO’s Department of Control of NTDs currently promotes intervention-based approaches
rather than disease-specific approaches. Each vertical disease program is resource intensive,
and resources are not maximized when they are fragmented. Integrating interventions should
allow a common approach for case detection and community-based diagnosis, resulting in
increased program efficiency through sharing of resources. We propose a new approach to
neglected tropical skin diseases, in which seven diseases are grouped together. Integration is
defined here to mean combining activities of two or more diseases at the same time and in the
same communities with the aim of increasing efficiency. Each country and region may adapt
the strategy to the prevailing local or regional co-endemicity of these diseases.
The following are reasons why a policy change to the integrated approach for skin NTDs is
feasible.
• Skin examination is an opportunity to identify multiple conditions in a single visit.
• Skin diseases can be suspected and diagnosed clinically by appropriately trained individuals,
including community health workers and village volunteers.
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• The case-management strategy of the skin diseases targeted is similar, including detection
and diagnosis by skin examination, with or without confirmation of the diagnosis by labora-
tory test, and treatment by the use of effective medicines (oral treatment and/or injection) or
morbidity and disability management.
Benefits and Challenges
The proposed integrated strategy may provide many benefits and opportunities:
1. Increased effectiveness and efficiency.
2. Increased impact of resources improving the opportunity and justification for investment.
3. Increased access to timely diagnosis of cases from the communities thus enhancing disease
surveillance.
4. Alleviation of poverty as a result of morbidity caused by NTDs.
5. Improved knowledge, capacity, and motivation of health workers and village volunteers
who may see only a few or none of these diseases in single vertical programmes.
6. Sustained awareness and knowledge of both declining and emerging diseases to enhance
surveillance.
7. Development of regional centres of excellence.
8. Improvement in skin health overall.
Despite the potential benefits, the following potential challenges should be acknowledged:
1. Loss of vertical programmes may lead to loss of specialized expertise.
2. Lack of adequately trained staff.
3. Staff attrition after training.
4. Referral centres may be unable to cope with the increased demand for skin NTD services.
5. Risk of developing a new vertical programme, which remains poorly integrated with the
existing health care system.
Description of Integrated IDM NTD Implementation
We propose three main linked activities in support of this integrated strategy (Box 1): firstly,
identification of areas of geographic overlap; secondly, the use of training packages for the
identification of multiple skin conditions; finally, integrated active case detection and use of
pathways for diagnosis and management in the local community as far as possible, with refer-
ral to local health centres and district hospitals as required.
Assessment of disease burden
The first step of the integrated approach is to establish the presence or absence of disease in
each district for the purpose of deciding the specific intervention(s) that might be required.
Initial mapping could be based on a combination of routine surveillance data and specific pop-
ulation-based surveys. These data can be used to classify the Implementation Unit (IU) as a
whole as being endemic or nonendemic. Usually the district level is identified as the IU, cover-
ing a population of 100,000–250,000, but the choice should be guided by feedback received
from lower administrative levels (i.e., if the skin NTD is very focal, a lower administrative level
such as sub-district may be chosen as the IU).
Passive surveillance data in health care facilities normally includes the patient’s village of
residence, which constitutes the basic mapping unit and allows identification of IUs with cur-
rent or historical cases of the skin NTDs.[16] However, hidden or unknown cases would not
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be identified through this approach. Counts from sub-IU regions or point locations of cases
during active case-finding can be collected by mobile teams visiting villages in affected areas.
Rapid assessment procedures are also emerging as useful tools that provide estimates of the
probability of local prevalence (e.g., prob[prevalence > 0.1]) for each IU rather than estimates
of the local prevalence itself.[17]
Training of health workers and village volunteers
The success of an integrated approach will rely on well trained health workers and village vol-
unteers being able to correctly identify multiple skin conditions. It is, therefore, necessary to
develop, validate, and implement structured training programmes for those who will be con-
ducting the field work as well as for the staff who will be training them. Simplified algorithms
(Table 2) have shown reasonable sensitivity and specificity in diagnosing a limited range of
skin conditions when compared to diagnoses made by dermatologists[18,19], but further work
is needed to expand these algorithms to cover the full range of common skin conditions and
skin NTDs. Simple integrated pictorial guides can also be developed to help health workers
and village volunteers. Structured teledermatology resources could provide a system of sup-
port.[20] Data collection could be augmented through the use of electronic data collection
tools and cloud-based data management, which have proven powerful in large-scale mapping
projects.[21]
Conduct active case detection
Scale-up of case detection activities is critical to effectively reduce the burden and transmission
of skin NTDs. Even in NTDs where mass drug administration (MDA) is the initial stage of
control interventions—such as yaws—as disease prevalence comes down, incident disease will
Box 1. Integrated IDM-NTDs Implementation Approach
• Initial assessment of disease burden: conduct surveys to identify endemic areas for
targeting intensified interventions.
• Training: validate a training program based on standardised clinical diagnostic
schemes and organise training for trainers, health workers, and village volunteers.
• Development of an integrated control strategy for each district: suggest interven-
tions to meet the specific needs of each district, depending on which diseases are iden-
tified in the initial assessment and survey.
• Social mobilisation: create demand for and a means of participating in interven-
tions, and address specific aspects and concerns related to the diseases.
• Active case detection: implement active case finding in schools and communities.
• Case management: establish a referral pathway to undertake early diagnosis and
treatment.
• Health facility mapping and strengthening: mapping health facilities in endemic
areas to guide the needed improvements in infrastructure, equipment, and supplies
to ensure optimum quality care of patients.
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still occur, for which individual diagnosis and treatment will be required to prevent resur-
gence.[22]
Different approaches to active case detection may be used. House-to-house screening strat-
egies yield the highest number of newly detected cases, though this strategy can be expensive
and difficult to sustain. Alternative strategies include mobile teams visiting villages to screen
all attendees at a central location or the use of an incentive-based approach, in which case
detection is done by trained health workers detecting cases in their health centre catchment
areas. In sub-Saharan Africa, trained village volunteers have also been instrumental in the
detection and referral of diseases such as Buruli ulcer, Guinea worm, and leprosy.[23,24] A
large network of village volunteers has also been pivotal in the Indian yaws elimination pro-
gram and the program to eliminate visceral leishmaniasis.[25]
Social mobilization activities will be needed prior to the start of active case detection pro-
grams. Communication efforts will focus on informing and enhancing knowledge among
the general public to engage people and strengthen their participation in case finding activi-
ties. Other social mobilization avenues, including mass media, will provide a common plat-
form by which to address social aspects associated with these diseases such as stigma and
discrimination.
Table 2. An example of key diagnostic signs for identification of targeted diseases.
Key sign identified by
HCW or village
volunteer
Diagnostic criteria utilised by
HCW or referral centre
Common differential diagnosis
Skin ulcer Presence of ulcerative lesions with
or without crusts
Buruli ulcer, Cutaneous leishmaniasis,
Yaws, Tropical ulcer, Stasis or venous
ulcerPresence of chronic nodules or
papillomatous lesions associated
with ulceration
Edges raised or indurated in CL and
yaws; edges undermined in BU
Subcutaneous mass Indurated painless swelling or mass
involving the foot
Mycetoma, Chromoblastomycosis, Buruli
ulcer nodule or plaque, Skin cancer,
Kaposi’s sarcoma, Onchocercal noduleHistory of penetrating injury at the
same site or walking barefoot in
mycetoma
Sinus tracts, chronic discharge and
grains in mycetoma
Well-demarcated firm subcutaneous
nodule(s) overlying a bony
prominence (e.g., iliac crest,
trochanters, ribs, sacrum) in
onchocerciasis
Swelling of limb or
legs
Painless non-pitting swelling Filarial lymphoedema, Podoconiosis, TB
lymphadenitis, Leprosy oedema, Buruli
ulcer oedema, Congestive heart failure
oedema
Skin patch Presence of a hypopigmented patch Leprosy, Pityriasis versicolor, Pityriasis
alba, VitiligoReduced sensation within the patch
in leprosy
Enlarged nerves in leprosy
Chronic duration (>3 months)
HCW, health care worker.
doi:10.1371/journal.pntd.0005136.t002
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Referral pathways
It will be important to establish clear referral pathways for people with positive findings on
screening for both suspected targeted diseases and non-targeted conditions, some of which
can be managed at frontline health care level.
Cases of skin NTDs will most often be detected at the community level by health workers
or volunteers and then referred to the nearest health facility for management. Cases that can-
not be managed at the primary health facility will be referred to the peripheral hospital. At this
level, diagnosis and management of minor complications like skin grafting should be done.
Complex cases should be referred to specialist referral centres. Community-based rehabilita-
tion programs will need to be strengthened to support the increased case load. Improvements
in the public health system are required to make treatment available and accessible at all levels.
Clinical diagnosis and laboratory confirmation
Clinical signs are of variable sensitivity in these diseases, so well-trained staff and diagnostic
tests have an important role on diagnosis. The manifestations of leprosy have overlapping clini-
cal features with many other skin diseases.[4] Chronic skin ulcers that fail to heal are a common
presentation for all three: BU, CL, and yaws (Fig 1).[2,3,6] Skin ulcers may also result from poly-
microbial infections, Haemophilus ducreyi,[13] and neuropathy (due to leprosy, diabetes) or
vascular disease. Lower limb swelling of filarial lymphoedema may be mistaken for podoconio-
sis, TB lymphadenitis, or systemic diseases such as heart failure (Fig 2).[7] The main differential
diagnoses of mycetoma are chromoblastomycosis and skin cancer.[5]
Skin ulcer. The diagnosis of skin ulcers in the tropics remains problematic as clinical fea-
tures alone are insufficient to make a decision on treatment. PCR diagnostic platforms in refer-
ence laboratories are used for confirmation of many conditions, but these facilities are remote
from the communities where the diseases occur. Sampling procedures like swabbing for detec-
tion of Mycobacterium ulcerans,[26] and Treponema pallidum subsp. pertenue[27] can be per-
formed in the field. Routine diagnosis of CL is based on detection of Leishmania spp. DNA in
the biopsy of skin lesions;[28] however, it is also possible to perform DNA analysis on impres-
sion smears from ulcerated CL lesions that can be collected in the field.[29] The main disad-
vantage of PCR is that sample transfer mechanisms from the field to reference laboratories for
testing are generally slow, resulting in delays and dropout during the diagnostic process.
Point-of-care tests (POCT) are available to aid clinicians to determine the etiology of skin
ulcers before the patient leaves the clinical setting. Fluorescent thin layer chromatography
(fTLC) is a simple and low-cost technique that can be used for detection of mycolactone in
skin swabs from BU lesions at a peripheral hospital laboratory using a small bench analyser;
[30] however, this test is still in the development stage. The Dual Path Platform (DPP) yaws
rapid test kit, which is based on simultaneous detection of antibodies to treponemal and non-
treponemal antigens, allows for serological diagnosis of yaws in the field.[31,32]
Subcutaneous mass. Multiple diagnostic tools are usually required to determine the extent
of infections and to identify the causative agents of mycetoma and guide treatment. Ultrasound
examination, fine-needle aspiration and deep-seated surgical biopsy need to be performed if
feasible. The ultrasound and examination of aspirated material can be POCTs. Surgical biopsies
can be processed for tissue histopathological examination, microbiology, and molecular studies.
Individuals suspected of having mycetoma will need to be referred for further imaging to deter-
mine the extent of disease.
Formal diagnosis of onchocerciasis is by skin snips to detect Onchocerca volvulus microfi-
lariae. Ultrasound of suspected onchocercal nodules may reveal dead or live adult worms.
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Limb swelling. Filarial lymphoedema is clinically difficult to distinguish from podoconio-
sis, but a diagnostic algorithm exists. Clinical diagnosis is accurate in settings where only podo-
coniosis is endemic; in settings where the two diseases may overlap, the combination of
clinical history, physical examination, and blood tests for antifilarial antibody (Wb123 assay)
have been used to reach a diagnosis.[33]
Skin patch. The diagnosis of leprosy is usually made clinically, which requires health
workers to be trained to recognise the varied presentations of the disease including the
immune-mediated leprosy reactional states. Skin biopsy is not routinely performed and
needs to be interpreted in conjunction with the clinical features. In two leprosy referral cen-
tres in Brazil, slit skin smears were only positive in 59%[34] of patients and have not been a
recommended part of leprosy programmes since 1998. Patients with suspected leprosy will
need to be referred for further assessment and diagnostic procedures where necessary.
Fig 1. Common skin ulcerative lesions related to neglected tropical diseases. (A) Buruli ulcer with undermined hanging edge, (B) Ill-defined
ulcerated infiltrated granulomatous-looking lesions on dorsum of the hand in cutaneous leishmaniasis, (C) Early-stage yaws ulcer with raised edge and
“raspberry” type appearance of the central granulation tissue, (D) Multiple yellow-crusted ulcers on the arms in secondary yaws. Images credit: Kingsley
Asiedu (A,D), Oriol Mitjà (C), Jorge Postigo (B).
doi:10.1371/journal.pntd.0005136.g001
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Individuals suspected of having leprosy need to be assessed for nerve function impairment,
and this needs to be repeated regularly during treatment and beyond.
Treatment
If skin NTDs are diagnosed and treated early, disabilities and disfigurements are preventable.
In addition, simple skin-directed therapy can contribute to enhanced resolution and reduction
in morbidity.
Specific interventions. Once a presumptive diagnosis is established, patients need to be
referred for confirmatory diagnosis or testing and treatment except for yaws, which can be
immediately treated at the time of detection using single-dose oral drugs (Table 3). Nonopioid
analgesics are usually sufficient for managing mild pain related to skin lesions; however, more
severe pain may complicate some diseases (e.g., neuropathic pain in leprosy or pain related to
erythema nodosum leprosum). For yaws, treatment of all household contacts is necessary,
even if they have no symptoms. The treatment of contacts of leprosy patients remains contro-
versial and raises ethical issues around disclosure of diagnosis.
Surgery is only occasionally needed for these diseases. In BU, antibiotic therapy (oral or
injectable) is largely replacing surgical excision of tissue in active disease; surgery followed by
physical therapy may be required for preventing contractures. In leprosy, surgery has long
been used to correct functional and stigmatising cosmetic impairments. Early localised myce-
toma lesions are amenable to surgical cure with a lower recurrence rate. Problematic oncho-
cercal nodules can be excised, and hanging groin in onchoceriasis is amenable to surgery to
reduce psychological distress.
Clinical wound care and repair of skin barrier function. Importantly, integrated but
nonspecific interventions can be implemented for case morbidity management that can bene-
fit patients with skin NTDs sharing similar basic pathologies.
Fig 2. Common skin neglected tropical diseases lesions. (A) Mycetoma with few active sinuses, grains, and discharge, (B) Bilateral lymphoedema
of both legs in the late stage of lymphatic filariasis, (C) Hypopigmented anaesthetic macules with infiltrated edge of borderline tuberculoid leprosy.
Images credit: Ahmed Fahal (A), CDC Public Health Image library (B), Rie Yotsu (C).
doi:10.1371/journal.pntd.0005136.g002
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Wound management is a common approach for most skin NTDs; hence, the provision of
appropriate dressings and training of health workers is important for a satisfactory outcome.
Effective wound management requires access to water and simple, cheap non-adherent dress-
ings, which keep wounds clean, protected from trauma, improve healing rates of damaged
skin, and potentially prevent transmission.
Skin barrier function improvement measures (e.g., washing, emollients, and compression
shoes) minimize the risk of further damage in filarial lymphoedema.[35,36] Provision of sim-
ple exercise regimens with or without compression can also improve lymphoedema. The use
of shoes is beneficial in the fight against several skin NTDs, and there are likely to be additional
benefits such as protection against tetanus, tungiasis, and soil-transmitted helminths.
Future Directions
An integrated approach to the skin NTDs has the potential to reduce transmission, delays in
diagnosis, and associated morbidity of these conditions and promote skin health for all. An
integrated approach also has the potential to reduce costs for both patients and health systems.
The WHO Department of Control of NTDs should take the lead in coordinating global efforts
with the support of donors and partners, focusing on key areas (Box 2). Publication of this
Table 3. Recommended diagnosis and management of suspected skin lesions.
Field
assessment
Initial
management
Laboratory
tools
Medical treatment Supportive
measures
Treatment of
contacts
Surgery Prevention of
disabilities and
rehabilitation
Buruli ulcer Clinical Swabbing,
registration
and referral
PCR of skin
swab samples
fTLC under
development
Oral rifampin
+ injectable
streptomycin or oral
clarithromycin for 8
weeks
Wound
dressing
No Yes Yes
Cutaneous
leishmaniasis
Clinical Swabbing,
registration
and referral
Microscopy
and PCR of
skin swab
Depends on species.
Local or systemic
therapy.
Wound
dressing
No No No
Filarial
lymphoedema
Clinical Registration
and referral
ICT antigen
test (usually
negative), and
antifilarial
antibodies
Oral
diethylcarbamazine
for 12
days ± doxycycline for
4 to 6 weeks
Skin barrier
function
improvement
measures
No Yes Yes
Oncocerciasis Clinical Registration
and referral
Skin snips.
Serological
and antigen
tests under
development
Oral ivermectin Pruritic rash
-treatment for
any itching and
secondary
infection
If in endemic
area
Yes for
nodules
or
hanging
groin
No
Leprosy Clinical Registration
and referral
Slit skin smear
or skin biopsy
material
Multidrug antibiotic
therapy for 6 or 12
months.
Home-based
self-inspections
and appropriate
footwear
Single dose
rifampicin is
being piloted
but is not
policy
Yes Yes
Mycetoma Clinical Registration
and referral
Microscopy
examination
and culture of
grains/biopsy
Depends on species.
Long term antibiotic or
antifungal.
Skin barrier
function
improvement
measures
No Yes Yes
Yaws Clinical Swabbing, and
immediate
treatment
DPP test and
PCR of skin
swab
Single oral dose of
azithromycin (2nd line:
injectable benzathine
penicillin)
Wound
dressing
Single dose
azithromycin
No No
fTLC, fluorescent thin layer chromatography; ICT, immunochromatography, DPP, dual path platform yaws assay.
doi:10.1371/journal.pntd.0005136.t003
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policy paper aims to trigger public debate about the approach and to encourage new funding
to be targeted towards management of these important NTDs.
Integration of surveillance and interventions will not be possible without considerable
political support, at a number of levels. There will be very real challenges to integration, includ-
ing relationships with donors, potential changes to NTD management structures, and com-
plexities in health care worker training among many others, and any of these challenges could
derail efforts to achieving integrated management. Strong relationships will be required
between governments, international agencies, implementing partners, and donors, with a clear
plan of action supported by an evidence base to move forward an agenda of integration.
Box 2. Next Steps
Advocacy
• Increasing awareness of skin NTDs and their impact on affected communities.
• Promoting integrated management schemes and their potential benefits to society and
donors.
• Networking technical and professional groups, donors, NGOs, endemic countries,
and different disease control programmes.
Policy
• Gaining consensus and support from all major stakeholders including the Ministries
of Health on the way forward for implementation.
• Promoting a common management strategy of these diseases at community and health
facility levels and resources required at each level.
Research
• Validating a clinical algorithm for identification of skin NTDs using key symptoms
and signs.
• Developing common clinical and laboratory diagnostic platforms for these diseases,
which are practical in the field.
• Mapping to identify their overlap to allow integrated coordinated control and treat-
ment activities as well as health system strengthening for service delivery.
• Piloting the integrated approach in one or several regions.
• Better understanding of the epidemiology of these diseases including transmission and
interaction with poverty and water, sanitation, and hygiene (WASH).
• Understand community resilience and program factors that strengthen community
participation.
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